Yoshinobu Nakada

Associate Professor

Tokai University School of Medicine

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Yoshinobu Nakada is an Associate Professor at Tokai University School of Medicine in Japan. His research interests focus on the integration of conventional and Kampo medicine in the treatment of various conditions, including gastroesophageal reflux disease, metabolic associated steatotic liver disease (MASLD), and mild to moderate COVID-19. He has contributed to numerous clinical studies aimed at improving treatment outcomes through innovative therapeutic approaches.

Articles (6)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Collaborators (6)

Ryutaro Arita

Assistant professor

Tohoku University Hospital

JAPAN

View details

Yasuhito Irie

JAPAN

View details

tatsuya nogami

Associate professor

Tokai University School of Medicine

JAPAN

View details

Shin Takayama

Specially appointed professor

Tohoku University

JAPAN

View details

Kazushi Uneda

JAPAN

View details

Takashi Kobayashi

Yokohama City University Graduate School of Medicine

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yoshinobu Nakada

Research Interests

Explore related searches

Contact this professor

About

Articles (6)

Rapid alleviation of severe epigastric pain associated with gastroesophageal reflux disease through the addition of orengedokuto to standard treatment: A clinical letter

Pemafibrate for treating MASLD complicated by hypertriglyceridaemia: a multicentre, open-label, randomised controlled trial study protocol

Zokumeito similar medicine, which is composed of makyokansekito and juzentaihoto, contributed to a rapid recovery of consciousness and physical functions for the sequelae of cerebral infarction: A case report

Conventional and Kampo Medicine Treatment for Mild-to-moderate COVID-19: A Multicenter, Retrospective, Observational Study by the Integrative Management in Japan for Epidemic Disease (IMJEDI Study-observation)

Kampo medicine in modern cardiology “1st International Symposium on Kampo Medicine”

Conventional and Kampo medicine in the treatment of mild to moderate COVID‐19: A multicenter, retrospective observational study protocol by the Integrative Management in Japan for Epidemic Disease (IMJEDI study‐Observation)

Collaborators (6)

Ryutaro Arita

Yasuhito Irie

tatsuya nogami

Shin Takayama

Kazushi Uneda

Takashi Kobayashi

Make your next move.